We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Committee Approval Moves First European Biologic Closer to Reality
EU Committee Approval Moves First European Biologic Closer to Reality
February 3, 2006
An advisory committee for the European Medicines Agency (EMEA) has recommended the approval of Sandoz’ human growth hormone Omnitrope, a move the company hopes will lead to the launch of the first generic biologic in Europe.